BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 35679711)

  • 1. Dysregulation of KRT19, TIMP1, and CLDN1 gene expression is associated with thyroid cancer.
    Martínez-Camberos A; Alvarez-Arrazola M; Arámbula-Meraz E; Romero-Quintana J; Luque-Ortega F; Romo-Martinez E; Sánchez-Urbina R; Cedano-Prieto D; González-Castillo A; García-Magallanes N
    Biochem Biophys Res Commun; 2022 Aug; 617(Pt 1):55-59. PubMed ID: 35679711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of potential novel biomarkers to differentiate malignant thyroid nodules with cytological indeterminate.
    Wu D; Hu S; Hou Y; He Y; Liu S
    BMC Cancer; 2020 Mar; 20(1):199. PubMed ID: 32164602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-gene molecular diagnostic model for thyroid cancer.
    Prasad NB; Kowalski J; Tsai HL; Talbot K; Somervell H; Kouniavsky G; Wang Y; Dackiw AP; Westra WH; Clark DP; Libutti SK; Umbricht CB; Zeiger MA
    Thyroid; 2012 Mar; 22(3):275-84. PubMed ID: 22280184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic and extent of disease multigene assay for malignant thyroid neoplasms.
    Kebebew E; Peng M; Reiff E; McMillan A
    Cancer; 2006 Jun; 106(12):2592-7. PubMed ID: 16688775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative detection of malignancy in fine-needle aspiration cytology (FNAC) smears with indeterminate cytology (Bethesda III, IV) by a combined molecular classifier.
    Titov S; Demenkov PS; Lukyanov SA; Sergiyko SV; Katanyan GA; Veryaskina YA; Ivanov MK
    J Clin Pathol; 2020 Nov; 73(11):722-727. PubMed ID: 32213552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next-Generation Sequencing Identifies a Highly Accurate miRNA Panel That Distinguishes Well-Differentiated Thyroid Cancer from Benign Thyroid Nodules.
    Mazeh H; Deutch T; Karas A; Bogardus KA; Mizrahi I; Gur-Wahnon D; Ben-Dov IZ
    Cancer Epidemiol Biomarkers Prev; 2018 Aug; 27(8):858-863. PubMed ID: 30049841
    [No Abstract]   [Full Text] [Related]  

  • 7. Diagnostic biomarkers of differentiated thyroid cancer.
    Kunavisarut T
    Endocrine; 2013 Dec; 44(3):616-22. PubMed ID: 23645523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of biomarkers in the diagnosis of uncertain samples of core needle biopsy of thyroid nodules.
    Xiong Y; Li X; Liang L; Li D; Yan L; Li X; Di J; Li T
    Virchows Arch; 2021 Nov; 479(5):961-974. PubMed ID: 34308507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analytical performance of the ThyroSeq v3 genomic classifier for cancer diagnosis in thyroid nodules.
    Nikiforova MN; Mercurio S; Wald AI; Barbi de Moura M; Callenberg K; Santana-Santos L; Gooding WE; Yip L; Ferris RL; Nikiforov YE
    Cancer; 2018 Apr; 124(8):1682-1690. PubMed ID: 29345728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of a multigene testing for preoperative evaluation of indeterminate thyroid nodules: A prospective blinded single center study in China.
    Song Y; Xu G; Ma T; Zhu Y; Yu H; Yu W; Wei W; Wang T; Zhang B
    Cancer Med; 2020 Nov; 9(22):8397-8405. PubMed ID: 32976686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA expression profile helps to distinguish benign nodules from papillary thyroid carcinomas starting from cells of fine-needle aspiration.
    Agretti P; Ferrarini E; Rago T; Candelieri A; De Marco G; Dimida A; Niccolai F; Molinaro A; Di Coscio G; Pinchera A; Vitti P; Tonacchera M
    Eur J Endocrinol; 2012 Sep; 167(3):393-400. PubMed ID: 22728346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined staining for immunohistochemical markers in the diagnosis of papillary thyroid carcinoma: improvement in the sensitivity or specificity?
    Wu G; Wang J; Zhou Z; Li T; Tang F
    J Int Med Res; 2013 Aug; 41(4):975-83. PubMed ID: 23857157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic markers differentiating follicular thyroid carcinoma from benign lesions.
    Freitas BC; Cerutti JM
    Mol Cell Endocrinol; 2010 May; 321(1):77-85. PubMed ID: 19932149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of molecular biomarkers for enhancing the management of cytologically indeterminate thyroid nodules and thyroid cancer.
    Duick DS
    Endocr Pract; 2012; 18(4):611-5. PubMed ID: 22849877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and prognostic value of angiogenesis-modulating genes in malignant thyroid neoplasms.
    Kebebew E; Peng M; Reiff E; Duh QY; Clark OH; McMillan A
    Surgery; 2005 Dec; 138(6):1102-9; discussion 1109-10. PubMed ID: 16360397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of a Multigene Genomic Classifier in Thyroid Nodules With Indeterminate Cytology: A Prospective Blinded Multicenter Study.
    Steward DL; Carty SE; Sippel RS; Yang SP; Sosa JA; Sipos JA; Figge JJ; Mandel S; Haugen BR; Burman KD; Baloch ZW; Lloyd RV; Seethala RR; Gooding WE; Chiosea SI; Gomes-Lima C; Ferris RL; Folek JM; Khawaja RA; Kundra P; Loh KS; Marshall CB; Mayson S; McCoy KL; Nga ME; Ngiam KY; Nikiforova MN; Poehls JL; Ringel MD; Yang H; Yip L; Nikiforov YE
    JAMA Oncol; 2019 Feb; 5(2):204-212. PubMed ID: 30419129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid nodule molecular profiling: The clinical utility of Afirma Xpression Atlas for nodules with Afirma Genomic Sequencing Classifier-suspicious results.
    Babazadeh NT; Sinclair TJ; Krishnamurthy V; Jin J; Heiden KB; Shin J; Berber E; Siperstein A
    Surgery; 2022 Jan; 171(1):155-159. PubMed ID: 34924179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A panel of four miRNAs accurately differentiates malignant from benign indeterminate thyroid lesions on fine needle aspiration.
    Keutgen XM; Filicori F; Crowley MJ; Wang Y; Scognamiglio T; Hoda R; Buitrago D; Cooper D; Zeiger MA; Zarnegar R; Elemento O; Fahey TJ
    Clin Cancer Res; 2012 Apr; 18(7):2032-8. PubMed ID: 22351693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of differentially expressed genes and long non-coding RNAs in papillary thyroid carcinoma diagnosis, progression, and prognosis.
    Cai WY; Chen X; Chen LP; Li Q; Du XJ; Zhou YY
    J Cell Biochem; 2018 Nov; 119(10):8249-8259. PubMed ID: 29968931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation Between Histological Diagnosis and Mutational Panel Testing of Thyroid Nodules: A Two-Year Institutional Experience.
    Shrestha RT; Evasovich MR; Amin K; Radulescu A; Sanghvi TS; Nelson AC; Shahi M; Burmeister LA
    Thyroid; 2016 Aug; 26(8):1068-76. PubMed ID: 27283257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.